Reuters logo
BRIEF-HTG Molecular Diagnostics says ‍entered amended and restated development and component supply agreement with illumina
June 2, 2017 / 10:07 PM / 5 months ago

BRIEF-HTG Molecular Diagnostics says ‍entered amended and restated development and component supply agreement with illumina

June 2 (Reuters) - HTG Molecular Diagnostics Inc:

* HTG Molecular Diagnostics - ‍entered amended and restated development and component supply agreement with illumina, inc effective may 31 - sec filing​

* HTG Molecular Diagnostics - ‍co required to pay illumina up to $0.6 million upon achievement of specified regulatory milestones relating to ivd test kits​

* HTG Molecular Diagnostics- agreed to pay illumina single digit percent royalty on net sales of ivd test kits co commercializes pursuant to restated deal ‍​

* HTG Molecular-‍filed amendment to prospectus supplement to increase amount of stock that may be offered in atm offering under sales deal to $40 million Source text - bit.ly/2rB1ciX Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below